Mahindra Life. (MAHLIFE)

FairStock Score: 37/100 — MIXED

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 174.49% and profit growth of 487.51% show strong near-term momentum
• Low debt/equity of 0.10 indicates a conservative balance sheet
• Piotroski F-Score of 7/9 suggests improving financial health
• Promoter holding of 52.41% provides reasonable alignment with minority shareholders
• PEG of 0.08 appears attractive if the high growth is sustainable

Concerns

• ROE of only 4.77% and ROCE of 2.20% reflect weak capital efficiency and limited moat
• P/E of 28.11 and P/B of 4.69 make the valuation expensive relative to current earnings power
• Real estate profits are cyclical; the 174.49% sales and 487.51% profit growth may be from a low base and not durable
• Dividend yield of just 0.78% provides negligible downside support

AI Analysis

Let me start with what attracts me: Mahindra Life has reported sales growth of 174.49% and profit growth of 487.51%, and with a PEG ratio of 0.08, the market appears to be paying very little for that growth. The latest quarter's ₹459 Cr sales and ₹109 Cr net profit confirm strong momentum. Financially, the balance sheet is conservative, with debt/equity of only 0.10, and a Piotroski F-Score of 7/9 suggests improving fundamentals. But I must slow down. The return on equity is just 4.77%, and ROCE is only 2.20% — these are poor numbers for any business I would call an investment. A P/E of 28.11 and P/B of 4.69 mean I am paying a rich multiple for a business that earns very little on the capital it employs. Book value is just ₹68.94, yet the market price is ₹323.20, over 4.6 times book. As Graham taught, price is what you pay, value is what you get, and here the underlying earning power seems thin. Real estate is cyclical; these growth numbers may be catch-up from a low base rather than durable compounding. A dividend yield of 0.78% offers little downside support. Promoter holding of 52.41% is adequate, but I want higher returns on capital before calling this a wonderful business. To buy this, I would need sustained high ROE, better ROCE, and proof that growth is not just one project cycle. This is an interesting fast grower, but not a classic Buffett franchise. I will keep it on my watch list, not in my comfort zone.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer